drugset / Trial / NCT06220123
A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
RandomizedParallel-groupOpen-labelPrevention
Summary
This study is designed to evaluate the efficacy and safety of SHR-2004 injection in preventing postoperative venous thromboembolism in patients undergoing ovarian cancer surgery.
Timeline
- Start
- 2024-02-16
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Enoxaparin sodium | Other / unclassified | — | — |
| Comparator | Rivaroxaban | Other / unclassified | — | — |
| Subject | SHR-2004 | Monoclonal antibody | — | — |
Indications
No indication recorded.